Start of Day MessageStart of Day Message LONDON, 13 Mar. 2025 (GLOBE NEWSWIRE) -- This is the... |
2024 FULL YEAR RESULTS2024 FULL YEAR RESULTS 2024 FULL YEAR RESULTS EBITDA and capacity target... |
Vopak hosts Capital Markets Day, reconfirms its strategic priorities …Vopak hosts Capital Markets Day, reconfirms its strategic priorities and... |
Bigbank AS Results for February 2025Bigbank AS Results for February 2025 Bigbank’s loan portfolio continued its... |
Vopak hosts Capital Markets Day, reconfirms its strategic priorities …Vopak hosts Capital Markets Day, reconfirms its strategic priorities and... |
![]() Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and …REGULATED INFORMATION Nyxoah Reports Fourth Quarter and Financial Year 2024... |
![]() Pharming Group reports fourth quarter and full year 2024 financial re…Full year 2024 total revenues increased by 21% to US$297.2 million and... |
Pharming Group reports fourth quarter and full year 2024 financial re…Pharming Group reports fourth quarter and full year 2024 financial results... |
Pharming Group reports fourth quarter and full year 2024 financial re…Pharming Group reports fourth quarter and full year 2024 financial results... |
Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and …Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and... |
RESULTATS ANNUELS 2024RESULTATS ANNUELS 2024 RESULTATS ANNUELS 2024 Objectifs d’EBITDA et de... |
![]() Avextra Unveils Promising Study Results at Major Pain CongressNew Data Highlights Superior Efficacy and Tolerability of Avextra 10/10 in... |
2024 FULL YEAR RESULTS2024 FULL YEAR RESULTS 2024 FULL YEAR RESULTS EBITDA and capacity target... |
Nyxoah Publie ses Résultats Financiers et Opérationnels pour le Quatr…Nyxoah Publie ses Résultats Financiers et Opérationnels pour le Quatrième... |
![]() Pharming Group reports fourth quarter and full year 2024 financial re…Full year 2024 total revenues increased by 21% to US$297.2 million and... |
![]() Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and …REGULATED INFORMATION Nyxoah Reports Fourth Quarter and Financial Year 2024... |
RESULTATS ANNUELS 2024RESULTATS ANNUELS 2024 RESULTATS ANNUELS 2024 Objectifs d’EBITDA et de... |
![]() RECOMMENDED CASH AND SHARE COMBINATION OF DOWLAIS GROUP PLC ("DOWLAIS…RECOMMENDED CASH AND SHARE COMBINATION OF DOWLAIS GROUP PLC ("DOWLAIS&q... |
PR Newswire - Start of DayPR Newswire - Start of Day PR Newswire LONDON, United Kingdom, March 13... |
WuXi XDC Wins Multiple Awards at Asia-Pacific Biopharma Excellence Aw…WuXi XDC Wins Multiple Awards at Asia-Pacific Biopharma Excellence Awards... |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions